Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization-Reference-Cited by-同舟云学术

Clinical conditions and treatment requirements for long‐term survival among hepatitis B‐related hepatocellular carcinoma initially treated with chemoembolization

Published:2019-07-17 Issue:11 Volume:8 Page:5097-5107
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Chen Zhen‐Xin¹²³,Jian Zhi‐Wei¹²³,Wu Xi‐Wen¹²³,Wang Jun‐Cheng¹²³,Peng Jing‐Yuan¹²³,Lao Xiang‐Ming¹²³^ORCID

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery Sun Yat‐sen University Cancer Center Guangzhou P. R. China

2. State Key Laboratory of Southern China Guangzhou P. R. China

3. Collaborative Innovation Center for Cancer Medicine Guangzhou P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2380

Reference61 articles.

1. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis

2. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update

3. Global cancer statistics, 2012

4. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma

5. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L;J Hepatol,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma;BMC Cancer;2023-03-13

2. Development of Models to Predict Postoperative Complications for Hepatitis B Virus-Related Hepatocellular Carcinoma;Frontiers in Oncology;2021-10-05

3. Analysis of factors affecting the prognosis of transcatheter arterial chemoembolization for hepatitis B-related hepatocellular carcinoma;Journal of Interventional Medicine;2021-05

4. Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma;Cancer Research and Treatment;2020-07-15